MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
MannKind has a consensus price target of $8.56.
The stock price for MannKind (NASDAQ: MNKD) is $5.82 last updated February 21, 2025 at 6:46 PM EST.
There are no upcoming dividends for MannKind.
MannKind’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.